High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
- PMID: 28487551
- DOI: 10.1038/ijo.2017.116
High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
Abstract
Background/objective: Central obesity and insulin resistance (IR) are common conditions in women with polycystic ovary syndrome (PCOS) and in subjects with non-alcoholic fatty liver disease (NAFLD). However, few studies have addressed the association between hyperandrogenism (HA) and NAFLD. We aimed to determine whether variations in the free androgen index (FAI) might be associated with NAFLD prevalence.
Subjects/methods: A cross-sectional study was performed including 400 Chinese women with PCOS and 100 age, and body mass index (BMI)-matched women. The anthropometric and serum biochemical parameters related to sex steroids, glucose and lipid profiles were examined. Liver fat content (LFC) was measured by quantitative ultrasound.
Results: The prevalence of NAFLD was 56.23% in PCOS patients and 38% in controls (P=0.001), and this prevalence increased with FAI quartile independently of obesity and homeostasis model assessment of insulin resistance (HOMA-IR). The FAI level increased from non-NAFLD group to NAFLD group. The FAI was positively associated with the metabolic parameters LFC, BMI, waist circumference, alanine aminotransferases, aspartate, triglyceride, total cholesterol and low-density lipoprotein cholesterol, and was negatively associated with high-density lipoprotein. Moreover, in multivariate logistic regression analysis BMI, high-sensitivity C-reactive protein (hsCRP), FAI, LFC and HOMA-IR were significantly associated with NAFLD. The cut-off values of FAI, LFC, BMI and hsCRP to predict NAFLD were 9.86%, 17.19%, 24.38% and 0.72%, respectively. The area under the curve for predicting NAFLD in PCOS patients showed comparable sensitivity and specificity between BMI and a new index combining FAI with hsCRP.
Conclusions: A higher FAI level is associated with increased LFC and NAFLD prevalence independent of obesity and IR.
Similar articles
-
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.J Endocrinol Invest. 2017 Dec;40(12):1279-1288. doi: 10.1007/s40618-017-0708-9. Epub 2017 Jun 13. J Endocrinol Invest. 2017. PMID: 28612285
-
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.Hum Reprod. 2016 Jun;31(6):1347-53. doi: 10.1093/humrep/dew076. Epub 2016 Apr 12. Hum Reprod. 2016. PMID: 27076501
-
Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.Reprod Biol Endocrinol. 2018 Mar 27;16(1):31. doi: 10.1186/s12958-018-0331-4. Reprod Biol Endocrinol. 2018. PMID: 29587769 Free PMC article.
-
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center.Arch Endocrinol Metab. 2020 May-Jun;64(3):235-242. doi: 10.20945/2359-3997000000242. Arch Endocrinol Metab. 2020. PMID: 32555989 Free PMC article.
-
Nonalcoholic fatty liver disease and polycystic ovary syndrome.World J Gastroenterol. 2014 Jul 14;20(26):8351-63. doi: 10.3748/wjg.v20.i26.8351. World J Gastroenterol. 2014. PMID: 25024594 Free PMC article. Review.
Cited by
-
Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome.Diabetes Metab Syndr Obes. 2022 Apr 24;15:1281-1291. doi: 10.2147/DMSO.S362424. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35494531 Free PMC article. Review.
-
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.Mol Metab. 2020 May;35:100937. doi: 10.1016/j.molmet.2020.01.001. Epub 2020 Feb 5. Mol Metab. 2020. PMID: 32244180 Free PMC article.
-
Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome.Rev Bras Ginecol Obstet. 2024 Dec 4;46:e-rbgo81. doi: 10.61622/rbgo/2024rbgo81. eCollection 2024. Rev Bras Ginecol Obstet. 2024. PMID: 39669304 Free PMC article.
-
Transcriptomics assisted by metabolomics analysis provides insights into regulation mechanisms during carcinogenic process in a hydrodynamically transfected liver cancer model.Cancer Cell Int. 2025 Aug 22;25(1):312. doi: 10.1186/s12935-025-03937-1. Cancer Cell Int. 2025. PMID: 40847407 Free PMC article.
-
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.J Endocrinol Invest. 2017 Dec;40(12):1279-1288. doi: 10.1007/s40618-017-0708-9. Epub 2017 Jun 13. J Endocrinol Invest. 2017. PMID: 28612285
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials